Announcement on Voluntary Disclosure of the Successful Enrollment of the 1st Subject in the Phase III Clinical Trial of ACC017 Tablets

About this update from Jiangsu Aidea Pharmaceutical Group Co., Ltd. Class A

Announcement on Voluntary Disclosure of the Successful Enrollment of the 1st Subject in the Phase III Clinical Trial of ACC017 TabletsThe abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Jiangsu Aidea Pharmaceutical Group Co., Ltd. Class A